Mathias Vormehr

Mathias Vormehr

Company: BioNTech SE

Job title: Director Cancer Vaccines

Seminars:

Panel Discussion: Exploring the Best-in-Class Adjuvant to Improve Patient Response to Neoantigen Therapy 3:00 pm

• Discussing the best approach to turn the ‘cold tumor’ into a ‘hot tumor’ • Outlining the variety of neoadjuvant methods to prime immune responses to neoantigen vaccination • Exploring the potential of a mRNA adjuvant if an mRNA vaccine platform is used for neoantigen deliveryRead more

day: Day Two

Overcoming Challenges for Effective Cancer Vaccine Therapy 2:30 pm

• Improving vaccine activity by combining with RNA encoded cytokines • Novel treatments to overcome immune escape via MHC I lossRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.